| MM | Multiple Myeloma |
| CGA | Comprehensive Geriatric Assessment |
| ADL | Activities of Daily Living |
| IADL | Instrumental Activities of Daily Living |
| IMWG | International Myeloma Working Group |
| IMWG-FI | International Myeloma Working Group Frailty Index |
| GAH | Geriatric Assessment in Hematology |
| FI-VIG | Frailty Index—Valoración Integral Geriátrica |
| CFS | Clinical Frailty Scale |
| R-MCI | Revised Myeloma Comorbidity Index |
| GLIM | Global Leadership Initiative on Malnutrition |
| BMI | Body Mass Index |
| MMSE | Mini-Mental State Examination |
| GDS | Geriatric Depression Scale |
| MNA-SF | Mini Nutritional Assessment—Short Form |
| EWGSOP2 | European Working Group on Sarcopenia in Older People (2nd ed.) |
| CTCAE | Common Terminology Criteria for Adverse Events |
| MRD | Minimal Residual Disease |
| PET-CT | Positron Emission Tomography—Computed Tomography |
| OR | Odds Ratio |
| CI | Confidence Interval |
| ROC | Receiver Operating Characteristic |
| AUC | Area Under the Curve |
| OS | Overall Survival |
| PFS | Progression-Free Survival |
| CR | Complete Response |
| VGPR | Very Good Partial Response |
| PR | Partial Response |
| DRd | Daratumumab, Lenalidomide, Dexamethasone |
| D-VMP | Daratumumab, Bortezomib, Melphalan, Prednisone |
| Rd | Lenalidomide, Dexamethasone |
| CCI | Charlson Comorbidity Index |
| R-ISS | Revised International Staging System |
| NA | Not Applicable |
| NI | No Information |
| SPSS | Statistical Package for the Social Sciences |
| IBM | International Business Machines (Corp.) |